PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 129 filers reported holding PROTAGONIST THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 4.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,465,771 | -17.0% | 147,828 | +37.5% | 0.00% | 0.0% |
| Q2 2023 | $2,969,730 | -40.7% | 107,521 | -50.6% | 0.00% | -33.3% |
| Q1 2023 | $5,008,227 | +210.0% | 217,749 | +47.1% | 0.00% | +200.0% |
| Q4 2022 | $1,615,422 | -39.2% | 148,068 | -53.0% | 0.00% | -50.0% |
| Q3 2022 | $2,657,000 | +5.8% | 315,194 | -0.7% | 0.00% | 0.0% |
| Q2 2022 | $2,511,000 | +197.5% | 317,499 | +790.5% | 0.00% | +100.0% |
| Q1 2022 | $844,000 | -82.1% | 35,656 | -74.1% | 0.00% | -66.7% |
| Q4 2021 | $4,711,000 | +419.4% | 137,751 | +169.1% | 0.00% | +200.0% |
| Q3 2021 | $907,000 | -72.1% | 51,185 | -29.4% | 0.00% | -50.0% |
| Q2 2021 | $3,256,000 | +31.3% | 72,540 | -24.2% | 0.00% | 0.0% |
| Q1 2021 | $2,479,000 | +1164.8% | 95,720 | +886.1% | 0.00% | – |
| Q4 2020 | $196,000 | +317.0% | 9,707 | +302.6% | 0.00% | – |
| Q3 2020 | $47,000 | -95.9% | 2,411 | -96.3% | 0.00% | -100.0% |
| Q2 2020 | $1,140,000 | +2180.0% | 64,547 | +819.2% | 0.00% | – |
| Q1 2020 | $50,000 | +25.0% | 7,022 | +24.5% | 0.00% | – |
| Q4 2019 | $40,000 | +400.0% | 5,639 | +709.0% | 0.00% | – |
| Q3 2019 | $8,000 | -84.0% | 697 | -83.0% | 0.00% | – |
| Q2 2019 | $50,000 | -84.3% | 4,107 | -83.8% | 0.00% | – |
| Q1 2019 | $319,000 | +275.3% | 25,351 | +99.7% | 0.00% | – |
| Q2 2018 | $85,000 | +400.0% | 12,697 | +536.4% | 0.00% | – |
| Q1 2018 | $17,000 | -52.8% | 1,995 | +14.0% | 0.00% | – |
| Q4 2017 | $36,000 | +3500.0% | 1,750 | +2677.8% | 0.00% | – |
| Q2 2017 | $1,000 | -50.0% | 63 | -56.2% | 0.00% | – |
| Q1 2017 | $2,000 | -98.8% | 144 | -98.1% | 0.00% | – |
| Q4 2016 | $168,000 | +1192.3% | 7,644 | +1130.9% | 0.00% | – |
| Q3 2016 | $13,000 | – | 621 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 2,449,183 | $56,331,209 | 18.32% |
| Kynam Capital Management, LP | 1,375,000 | $31,625,000 | 4.08% |
| BVF INC/IL | 3,775,900 | $86,845,700 | 3.18% |
| Cormorant Asset Management, LP | 1,700,000 | $39,100 | 2.58% |
| RTW INVESTMENTS, LP | 4,600,799 | $105,818,377 | 2.20% |
| Ghost Tree Capital, LLC | 225,000 | $5,175,000 | 1.53% |
| 683 Capital Management, LLC | 791,000 | $18,193,000 | 1.36% |
| Ikarian Capital, LLC | 211,400 | $4,862,200 | 1.10% |
| Ikarian Capital, LLC | 211,400 | $4,862,200 | 1.10% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 105,486 | $2,426,178 | 1.00% |